AKT1 and neoplasm: Further, the gene expression profiling of the tumour exhibited a higher level of EPCAM, CK20, KRAS, AKT1, BRAF and CD133 expression, while lower levels of expression were observed in NANOG, MMP9 and APC genes (Figure 2B).